The newly committed suite is the first of four manufacturing suites ProMed is constructing at Niagara Lane to support growing demand for manufacture of ophthalmic implants and other sustained-release ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry.Deep ...

Merck is in talks to buy cancer drug developer Revolution Medicines in a $28 billion to $32 billion deal, the Financial Times ...

A new report indicates that U.S. drugmakers will raise prices on at least 350 medications despite pressure from President ...

Funding supports safety studies, manufacturing and clinical planning needed before applying to test the treatment in patients ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

It’s been more than ten years since the FDA signed off on the United States’ first biosimilar product, opening up what was ...

Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 ...

The big news in the drug sector is the emergence of GLP-1 weight loss drugs, but dig deeper, and you'll find relatively cheap ...